{{多個問題|
{{expand English|ga=yes}}
{{Expand|time=2017-11-12T19:01:15+00:00}}
}}

{{Infobox drug
| drug_name = 
| type = combo
| image = Racemic amphetamine 2.svg
| alt = an image of the amphetamine skeletal formula
| caption = 
| image2 = D-Amphetamine-3D-balls.png
| alt2 = a 3d image of the dextroamphetamine compound found in Adderall
<!--Combo data-->
| tradename = Adderall, Adderall XR, Mydayis
| Drugs.com = {{drugs.com|monograph|Adderall}}
| component1 = amphetamine aspartate monohydrate
| class1 = 25% – [[兴奋剂|中樞神經刺激劑]]<br />({{nowrap|12.5% {{abbr|levo|levoamphetamine}}; 12.5% {{abbr|dextro|dextroamphetamine}}}})
| component2 = amphetamine sulfate
| class2 = 25% – 中樞神經刺激劑<br />({{nowrap|12.5% {{abbr|levo|levoamphetamine}}; 12.5% {{abbr|dextro|dextroamphetamine}}}})
| component3 = dextroamphetamine saccharate
| class3 = 25% – 中樞神經刺激劑<br />({{nowrap|0% {{abbr|levo|levoamphetamine}}; 25% {{abbr|dextro|dextroamphetamine}}}})
| component4 = dextroamphetamine sulfate
| class4 = 25% – 中樞神經刺激劑<br />({{nowrap|0% {{abbr|levo|levoamphetamine}}; 25% {{abbr|dextro|dextroamphetamine}}}})
<!--Clinical data-->
| MedlinePlus = a601234
| licence_EU = 
| licence_US = Adderall
| pregnancy_AU = 
| pregnancy_US = C
| pregnancy_category = 
| legal_AU = S8
| legal_CA = Schedule I
| legal_DE = Anlage III
| legal_NZ = Class B
| legal_UK = Class B
| legal_US = Schedule II
| legal_UN = Psychotropic Schedule II
| legal_status = 
| dependency_liability = [[身体依赖|生理]]: 無<ref name="NHM-physical dependence">{{cite book | vauthors = Malenka RC, Nestler EJ, Hyman SE | editor = Sydor A, Brown RY | title = Molecular Neuropharmacology: A Foundation for Clinical Neuroscience | year = 2009 | publisher = McGraw-Hill Medical | location = New York | isbn = 9780071481274 | page = 367 | edition = 2nd | chapter = Chapter 15: Reinforcement and Addictive Disorders | quote= While physical dependence and withdrawal occur with some drugs of abuse (opiates, ethanol), these phenomena are not useful in the diagnosis of addiction because they do not occur with other drugs of abuse (cocaine, amphetamine) and can occur with many drugs that are not abused (propranolol, clonidine).}}</ref><br />[[精神依赖|心理]]: 中等<ref name="Stahl's Essential Psychopharmacology">Stahl SM (March 2017). "Amphetamine (D,L)". Prescriber's Guide: Stahl's Essential Psychopharmacology (6th ed.). Cambridge, United Kingdom: Cambridge University Press. pp. 45–51. ISBN 9781108228749. Retrieved 5 August 2017.</ref>
| addiction_liability = 中等
| routes_of_administration = [[口腔|口服]]、{{tsl|en|Insufflation (medicine)||噴射}}、[[栓剂|栓剂]]、[[口腔黏膜吸收|口腔黏膜吸收]]
<!--Identifiers-->
| CAS_number = 300-62-9
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_supplemental = {{CAS|51-64-9}}
| ATC_prefix = N06
| ATC_suffix = BA02
| ATC_supplemental = {{ATC|N06|BA01}}
| PubChem =  3007
| IUPHAR_ligand = 4804
| DrugBank = DB00182
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID = 13852819
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| KEGG = D03740
| KEGG_Ref = {{keggcite|correct|kegg}}
| ChEBI = 2679
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 405
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| synonyms =
<!--Chemical data-->
| verifiedrevid = 578643702
}}
{{medical}}
'''阿得拉尔'''或'''阿得拉'''（{{lang-en|Adderall}}、{{lang|en|Adderall XR}}、{{lang|en|Mydayis}}）是一种{{tsl|en|combination drug|复方药}}，包含[[中樞神經系統|中樞神經系統]][[兴奋剂|兴奋剂]][[苯丙胺|苯丙胺]]的两种[[对映异构|对映异构体]]的四种[[盐_(化学)|盐类]]。阿得拉尔主要用于治疗[[注意力不足過動症|注意力不足過動症]]（ADHD）和[[發作性嗜睡病|發作性嗜睡病]]，也有人用它作{{tsl|en|Performance-enhancing substance|增强表现药物|运动员兴奋剂}}和[[益智药|益智药]]，以及享乐时用作[[春药|春药]]和[[欣快|欣快剂]]。

==文獻來源==
{{reflist}}

{{ADHD pharmacotherapies}}

[[Category:苯丙胺|Category:苯丙胺]]
[[Category:複方藥|Category:複方藥]]
[[Category:作用于心血管系统的药物|Category:作用于心血管系统的药物]]
[[Category:作用于神经系统的药物|Category:作用于神经系统的药物]]
[[Category:安乐药|Category:安乐药]]
[[Category:促智药|Category:促智药]]
[[Category:苯乙胺类|Category:苯乙胺类]]
[[Category:兴奋剂|Category:兴奋剂]]
[[Category:苯丙胺类|Category:苯丙胺类]]
[[Category:VMAT抑制药|Category:VMAT抑制药]]
[[Category:注意力不足過動症|Category:注意力不足過動症]]
{{medical small}}